Marijuana legalization across many states has opened various avenues and unsheathed its versatility. The ingenuity on display regarding ideas for its use is incredible. Medicinal marijuana products are expanding at an unprecedented rate.
Historical evidence shows that cannabis is an excellent and more effective substitute for leading traditional painkillers. Additionally, it has been known to significantly limit seizures in severe conditions such as epilepsy.
Now, a revolutionary product, MedChewRx, is pushing the envelope further.
MedChewRx is the first of its kind pharmaceutical, functional chewing gum containing cannabinoids. It is a gum which treats chronic pain, specifically fibromyalgia.
Developed by AXIM Biotech, it is formulated with 5 mg of cannabidiol (CBD) and 5 mg of tetrahydrocannabinol (THC). CBD the non-psychoactive ingredient acts as a blocker against signals being sent by the pain receptors to the brain. Hence, numbing the pain whilst not making you ‘high’.
The gum works faster than smoking as it bypasses the liver. The CBD reacts with saliva to quickly enter the bloodstream and does not get processed by any other internal organ.
Benefits to the pain-ridden include:
- Stress Relief
- Cardiovascular stimulation
- Nuerostimulatory and neuroprotective effects on the brain
- Checks age-related cognitive decline
Being more socially acceptable than smoking also goes in favor of the gum. Sufferers will be able to relieve their pain anywhere and at any time.
Currently being tested, AXIM Biotech claims that the gum will be available for purchase next year.